Clinical Trial Update: AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial results for AtriCure's bipolar radiofrequency ablation in permanent atrial fibrillation have been completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AtriCure Bipolar Radiofrequency Ablation

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2013-03-14